Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke

Journal of the American College of Cardiology

Volumn 56, Issue 13, 2010, Pages 1045-1053

  Katan, Mira ^a   Fluri, Felix ^a   Schuetz, Philipp ^a   Morgenthaler, Nils G ^b   Zweifel, Christian ^a   Bingisser, Roland ^a   Kappos, Ludwig ^a   Steck, Andreas ^a   Engelter, Stefan T ^a   Mller, Beat ^a,c   Christ Crain, Mirjam ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BRAHMS AG   (Germany)

^c Kantonsspital ^*  (Switzerland)

Author keywords

biomarker; MR proANP; outcome; stroke

Indexed keywords

ATRIAL NATRIURETIC FACTOR; MIDREGIONAL PRO ATRIAL NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIDREGIONAL PRO-ATRIAL NATRIURETIC PEPTIDE, HUMAN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; BLOOD; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; STROKE;

EID: 77956635871     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.02.071     Document Type: Article

References (42)

1. K.R. Lees, J.A. Zivin, and T. Ashwood NXY-059 for acute ischemic stroke N Engl J Med 354 2006 588 600
2. W. Rosamond, K. Flegal, and K. Furie Heart disease and stroke statistics2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117 2008 e25 e146
3. G.J. Hankey, and C.P. Warlow Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations Lancet 354 1999 1457 1463
4. S.C. Johnston Clinical practice Transient ischemic attack N Engl J Med 347 2002 1687 1692
5. T.J. Wang, M.G. Larson, and D. Levy Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
6. T.J. Wang, P. Gona, and M.G. Larson Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 2006 2631 2639
7. V. Estrada, M.J. Tellez, J. Moya, R. Fernandez-Durango, J. Egido, and A.F. Fernandez Cruz High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke Am J Hypertens 7 1994 1085 1089
8. A.M. Makikallio, T.H. Makikallio, and J.T. Korpelainen Natriuretic peptides and mortality after stroke Stroke 36 2005 1016 1020
9. R. Giuffrida, M. Bellomo, G. Polizzi, and L.S. Malatino Ischemia-induced changes in the immunoreactivity for endothelin and other vasoactive peptides in the brain of the Mongolian gerbil J Cardiovasc Pharmacol 20 Suppl 12 1992 S41 S44
10. M. Nogami, J. Shiga, A. Takatsu, N. Endo, and I. Ishiyama Immunohistochemistry of atrial natriuretic peptide in brain infarction Histochem J 33 2001 87 90
11. S. Rubattu, R. Stanzione, and E. Di Angelantonio Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans Stroke 35 2004 814 818
12. M. Ala-Kopsala, J. Magga, and K. Peuhkurinen Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A-and B-type natriuretic peptides Clin Chem 50 2004 1576 1588
13. N.G. Morgenthaler, J. Struck, B. Thomas, and A. Bergmann Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma Clin Chem 50 2004 234 236
14. T. Omland, A. Persson, and L. Ng N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918
15. T. Omland, J.A. de Lemos, and D.A. Morrow Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes Am J Cardiol 89 2002 463 465
16. A. Gegenhuber, T. Mueller, B. Dieplinger, W. Poelz, R. Pacher, and M. Haltmayer B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure Clin Chim Acta 370 2006 174 179
17. A. Gegenhuber, J. Struck, and W. Poelz Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP Clin Chem 52 2006 827 831
18. M. Christ, A. Thuerlimann, and K. Laule Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea Eur J Clin Invest 37 2007 834 841
19. M. Katan, F. Fluri, and N. Morgenthaler Copeptin a novel, independent prognostic marker in patients with ischemic stroke Ann Neurol 66 2009 799 808
20. J. Bamford, P. Sandercock, M. Dennis, J. Burn, and C. Warlow Classification and natural history of clinically identifiable subtypes of cerebral infarction Lancet 337 1991 1521 1526
21. H.P. Adams Jr., B.H. Bendixen, and L.J. Kappelle Classification of subtype of acute ischemic stroke Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41
22. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
23. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
24. D. Staub, N. Jonas, and M.J. Zellweger Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia Am J Med 118 2005 1287
25. A. Gegenhuber, J. Struck, and B. Dieplinger Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure J Card Fail 13 2007 42 49
26. J. Montaner, M. Perea-Gainza, and P. Delgado Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers Stroke 39 2008 2280 2287
27. P. Appelros, I. Nydevik, and M. Viitanen Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year Stroke 34 2003 122 126
28. G. Giannakoulas, A. Hatzitolios, and H. Karvounis N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke Angiology 56 2005 723 730
29. K. Nakagawa, T. Yamaguchi, and M. Seida Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke Cerebrovasc Dis 19 2005 157 164
30. T. Etgen, H. Baum, K. Sander, and D. Sander Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis Stroke 36 2005 270 275
31. J. Klingelhofer, and D. Sander Cardiovascular consequences of clinical stroke Baillieres Clin Neurol 6 1997 309 335
32. D. Sander, K. Winbeck, J. Klingelhofer, T. Etgen, and B. Conrad Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke Neurology 57 2001 833 838
33. P. James, C.J. Ellis, R.M. Whitlock, A.R. McNeil, J. Henley, and N.E. Anderson Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study Bmj 320 2000 1502 1504
34. G.W. Petty, R.D. Brown Jr., J.P. Whisnant, J.D. Sicks, W.M. O'Fallon, and D.O. Wiebers Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989 Neurology 50 1998 208 216
35. T. Moulin, L. Tatu, F. Vuillier, E. Berger, D. Chavot, and L. Rumbach Role of a stroke data bank in evaluating cerebral infarction subtypes: patterns and outcome of 1,776 consecutive patients from the Besancon stroke registry Cerebrovasc Dis 10 2000 261 271
36. Cardiogenic brain embolism Cerebral Embolism Task Force Arch Neurol 43 1986 71 84
37. C. Foerch, M.T. Wunderlich, and F. Dvorak Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke Stroke 38 2007 2491 2495
38. C.J. Smith, H.C. Emsley, and C.M. Gavin Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome BMC Neurol 4 2004 2
39. A. Rosell, J. Alvarez-Sabin, and J.F. Arenillas A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke Stroke 36 2005 1415 1420
40. A. Rosell, E. Cuadrado, A. Ortega-Aznar, M. Hernandez-Guillamon, E.H. Lo, and J. Montaner MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke Stroke 39 2008 1121 1126
41. J. Struck, N.G. Morgenthaler, and A. Bergmann Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients Peptides 26 2005 2500 2504
42. B. Zethelius, L. Berglund, and J. Sundstrom Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116